Evidence map›Paper›PMID 33062247›Full record

ArticleParkinson's disease2020

Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson's Disease.

Dengjun Guo, Bing Han, Yuqiang Lu, Chenling Lv, Xiaoling Fang, Zhenzhong Zhang, Zhenguo Liu, Xiaoping Wang

Abstract read
In one paragraph

Article in Parkinson's disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Revue d'epidemiologie et de sante publique · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dengjun GuoTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.ORCID https://orcid.org/0000-0001-5017-5544
Bing HanTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
Yuqiang LuTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
Chenling LvTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
Xiaoling FangTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
Zhenzhong ZhangTongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
Zhenguo LiuXinhua Hospital, Shanghai Jiaotong University Medical School, Shanghai 200092, China.
Xiaoping WangTongren Hospital, Shanghai Jiao Tong University Medical School, Shanghai 200336, China.ORCID https://orcid.org/0000-0002-2936-5877

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study investigated the influence of lockdown during the 2019 coronavirus disease (COVID-19) pandemic on the quality of life of patients with Parkinson's disease (PD).

methodsWe conducted a questionnaire survey involving 113 patients with PD from Xihu District, Hangzhou, Zhejiang. During the epidemic prevention and control period (February 1 to March 31, 2020), patients enrolled were asked to fill out questionnaires, including the "COVID-19 Questionnaire for PD Patients during the Period of Epidemic Prevention and Control" and "39-item Parkinson's Disease Questionnaire (PDQ-39)." During the phase of gradual release of epidemic prevention and control (April 1 to April 30, 2020), all patients were followed up again, and PDQ-39 questionnaires were completed.

resultsThe quality of life for patients during the period of epidemic prevention and control was worse than that after epidemic prevention and control (

conclusionsThe inconvenient treatment during the pandemic directly caused the aggravation of patients' symptoms and the decline in their quality of life. It is suggested that social media (such as WeChat or Tencent QQ) are used for regular interactions and follow-up appointments for patients with inconvenient medical treatment.

Identifiers

PMID33062247
PMCPMC7537675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.